ABSTRACT Objective: To determine the cost-effectiveness of nurse practitioners delivering primary and specialised ambulatory care.
INTRODUCTION
Ambulatory care encompasses a broad range of personal healthcare services that do not require an overnight hospital stay. 1 This is the defining feature of ambulatory care, not the setting or type of service, both of which are quite varied. Settings can be community or hospital based. Services can include diagnosis, observation, monitoring, consultation,
Strengths and limitations of this study
▪ Our review used a comprehensive search strategy to identify relevant trials that evaluated formallytrained or licensed nurse practitioners delivering primary or specialised ambulatory care. ▪ The quality of the trials and individual outcomes was assessed using the Cochrane risk of bias criteria, Quality of Health Economic Studies (QHES) instrument and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. ▪ Outcomes that were reported in more than one study were combined using meta-analysis; opportunities were limited because trials did not use common outcome measures, to facilitate the pooling of results. ▪ There is high-quality evidence that nurse practitioners in alternative provider ambulatory primary care roles are cost-effective with patient outcomes that are equivalent to or better than usual care and with lower costs; the evidence for their costeffectiveness in alternative provider specialised ambulatory care roles is promising, but limited by the small number of studies; it was not possible to draw conclusions about the cost-effectiveness of the complementary provider specialised ambulatory care role of nurse practitioners because of the generally low quality of evidence. ▪ Three trials of the nurse practitioner role in ambulatory primary care evaluated a narrow scope of the nurse practitioner role because the intervention was limited to a single visit with patients seeking same day consultations for common complaints.
prevention, treatment, rehabilitation, and diagnostic, therapeutic or surgical procedures. This paper focuses on ambulatory primary care and ambulatory specialty care. We define the former as a full range of comprehensive services, including diagnosis and treatment of undifferentiated health problems longitudinally over time and the latter as focused services for a specific population with the same condition or need for specific services. Improving the quality of ambulatory care services within a value for cost framework is a world-wide challenge. [2] [3] [4] In response, new healthcare provider roles have been developed and existing roles adapted. Introduced in North America more than 50 years ago, nurse practitioners carry out a range of activities, some of which overlap with activities traditionally performed by physicians. 5 The extent to which nurse practitioner roles are autonomous or supervised varies within 6 and across 5 countries, and their acceptance by physicians is inconsistent. 7 Nurse practitioners function in alternative or complementary roles. 8 In alternative roles nurse practitioners provide similar services to those for whom they are substituting, usually physicians, whereas in complementary roles nurse practitioners provide additional services that are intended to complement or extend existing services. Usually the health service aim of the former is to reduce cost or workload or to address workforce shortages, while for the latter it is to improve quality of care.
Research dating back to the 1970s 9 and in subsequent reviews [10] [11] [12] [13] has shown that nurse practitioners in either alternative or complementary roles provide high-quality patient care that results in high patient and provider satisfaction. What is unclear is whether or not nurse practitioner care is cost-effective. 12 This information along with information about the influence of nurse practitioner care on patient and provider outcomes is needed for decision-making to achieve the triple aim of better health, better care and better value. 14 The purpose of this paper is to report a systematic review of 11 randomised controlled trials that assessed the costeffectiveness of nurse practitioners in primary and specialised ambulatory care. These trials are part of a larger systematic review of 43 trials examining the cost-effectiveness of advanced practice nurses in various settings.
METHODS

Selection of studies
We included trials evaluating nurse practitioners working in alternative or complementary provider roles in primary or specialised ambulatory care. We required papers to specify, or the author to confirm, that nurse practitioners had completed a formal nurse practitioner education programme and/or were licensed as nurse practitioners. Studies were excluded if the control group was exposed to a nurse practitioner or the nurse practitioner contribution to an intervention could not be isolated from other healthcare providers on the team.
The primary outcomes of interest in this review of nurse practitioner cost-effectiveness were objective measures of health system utilisation. These included use of services (eg, length of consultation, referrals, emergency department visits, hospitalisations), costs of healthcare (eg, personnel costs, medications, family costs) and health resource use (eg, diagnostic tests). Since health system utilisation must be considered in the context of patient and provider outcomes, additional primary outcomes of interest were patient health status, quality of life, and satisfaction, as well as provider outcomes such as quality of care and job satisfaction. Studies were excluded if they did not include a measure of health system utilisation.
Identification of studies
We searched for relevant published and unpublished trials reported from 1980 to July 2012 without restrictions on jurisdiction or language (figure 1). We searched 10 electronic bibliographic databases, handsearched key journals, reviewed reference lists of relevant papers, searched websites and contacted authors. We updated the database search by repeating it for the period from 31 July 2012 to 31 July 2013. More details about the search strategy and study protocol can be found elsewhere. 15 After duplicates were removed, two-member teams independently screened titles and abstracts for relevance followed by full-text review of eligible papers. Discrepancies were resolved through discussion. A research assistant extracted data from each relevant study. Team members checked the accuracy of extractions and discrepancies were resolved through discussion leading to consensus. Findings from a single study reported in two or more papers were extracted as one study.
Assessment of study quality Two researchers independently assessed the quality of studies for internal validity using a slightly modified version of the Cochrane risk of bias criteria 16 and resolved disagreements through discussion. Eight questions were each assigned a high, low or unclear risk of bias following which an overall risk of bias was assigned to the study as follows: low risk of bias (at risk in 0-1 category), moderate risk of bias (at risk in 2-3 categories), high risk of bias (at risk in 4-6 categories), and very high risk of bias (at risk in 7-8 categories).
Using the Quality of Health Economic Studies instrument, [17] [18] [19] [20] two research assistants independently assessed each study for rigour of the economic analysis. Studies were stratified according to quartiles for extremely poor quality (0-24), poor quality (25-49), fair quality (50-74) and high quality (75-100). 19 We evaluated the quality of the body of evidence for individual outcomes using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system 21 and GRADEpro software. The quality of evidence was considered 'high level' until downgraded based on potential risk of bias, inconsistency in results, indirectness of evidence, imprecision of results or high probability of publication bias.
Data analysis
Studies were separated into three groups: (1) alternative provider role in ambulatory primary care; (2) alternative provider role in ambulatory specialised care; and (3) complementary provider role in ambulatory specialised care (none of the studies evaluated the complementary provider role in primary care). All findings were tabulated separately by outcome with corresponding GRADE quality ratings within these groups. If outcomes were sufficiently similar, we combined data in a meta-analysis. For continuous outcome variables, we calculated a weighted mean difference with a 95% CI. For dichotomous outcomes, we calculated a pooled risk ratio. Given the small number of studies eligible for pooling, we used a fixed-effects model. We investigated statistical heterogeneity by visual inspection of the forest plots, applying the χ 2 test for homogeneity and calculating the I 2 statistic. 16 
RESULTS
Eleven trials of nurse practitioners in primary and specialised ambulatory care met our inclusion criteria ( figure 1 ). The studies were conducted in USA, UK, or the Netherlands, and most were published in the year 2000 or later. Table 1 provides a brief overview of each study (see online supplemental file 1 for more detail).
Alternative provider nurse practitioner role in ambulatory primary care Four non-inferiority trials assessed whether nurse practitioners in alternative provider primary care roles could function at least at the level of physician comparators, 5 Open Access with equal or lower costs. [22] [23] [24] [25] [26] [27] [28] In three trials, the intervention was limited to a single visit with patients seeking same day consultations for common complaints with a follow-up of 2-4 weeks. 22 24 28 The nurse practitioners worked as part of primary care teams alongside general practitioners who were available for consultation and to sign off prescriptions. In contrast, Mundinger et al 25 evaluated nurse practitioner care over a 2-year period providing ambulatory care for all adults with oversampling of patients with asthma, diabetes and hypertension. Nurse practitioners independently staffed a primary care clinic and sought off-site physician consultation when needed. The nurse practitioners had full authority to prescribe, refer to specialists and admit patients to hospital.
Based on the Cochrane risk of bias assessment, one trial was at low 25 and three at moderate risk of bias. 22 24 28 The Quality of Health Economic Studies scores ranged from a high of 62 22 to a low of 34.
24
Patient/provider outcomes are reported in a detailed table in online supplemental file 2. Using GRADE, each outcome was assessed as high (HQE), moderate (MQE), low (LQE), or very low quality evidence (VLQE). In all four studies 22 24 25 28 nurse practitioner care was at least equivalent to general practitioner care in patient health status outcomes. For patients with hypertension in one study, 25 the drop in diastolic blood pressure at 6 months was larger in the nurse practitioner group (356 patients) (mean difference: −3.0 mm Hg (95% CI −5.54 to −0.46); p=0.04) (LQE). Based on a meta-analysis of two studies in which the nurse practitioners had at least 1 year experience, 24 28 nurse practitioner care was associated with higher patient satisfaction (1515 patients; I 2 =0%) (mean difference: 0.15 (95% CI 0.11 to 0.20); p<0.0001) and parent satisfaction (804 parents; I 2 =0%) (mean difference: 0.23 (95% CI 0.16 to 0.30); p<0.0001) (both 5-point Likert scales; both HQE). In the trial of newly established nurse practitioner roles, 22 nurse practitioner care was associated with higher patient satisfaction in the subgroup of patients with chronic disease (583 patients) (mean difference: 0.24 (95% CI 0.05 to 0.43); p=0.02) (11- table 2 shows, in three studies nurse practitioners had longer consultation times than general practitioners. 22 24 28 Based on moderate quality evidence that included meta-analysis of two studies with over 2500 patients, 22 28 the mean total consultation time in the nurse practitioner group was 4.1 min longer per patient (95% CI 3.7 to 4.5; p<0.0001). Heterogeneity was where studies at risk in ≤1 category were judged to be at low risk of bias; 2-3 categories at moderate risk; 4-6 at high risk; and 7-8 categories at very high risk of bias. The QHES measured the quality of studies with respect to their health economic analysis. [17] [18] [19] The score ranged from 0 to 100 where studies scoring from 0-24 points were judged to be extremely poor quality, 25-49 were poor, 50-74 were fair, and 75-100 were high quality. ED, emergency department; GP, general practitioner; HMO, health maintenance organisation; MD, medical doctor; NIDDM, non-insulin dependent diabetes mellitus; NP, nurse practitioner; QHES, Quality of Health Economic Studies. 7 Open Access considerable (I 2 =97%). A third study found that nurse practitioner consultations were significantly longer in 8 of 10 practices; the ratio of general practitioner to nurse practitioner consultation times varied from 0.57 (95% CI 0.49 to 0.67) to 0.92 (95% CI 0.7 to 1.21). 24 Two studies reported on the number of patients asked to make a return visit. 22 28 These data were combined, and based on moderate quality evidence, nurse practitioners were more likely to ask patients to return than the general practitioners (2562 patients; I 2 =76% (RR 1.32, 95% CI 1.20 to 1.46); p<0.0001). The number of patients who made return visits within 2 weeks for the index reason was reported in three trials. 22 24 28 A meta-analysis, including almost 3500 patients (I 2 =5%), indicated that more nurse practitioner patients than general practitioner patients made return visits for the same problem 22 or within 2 weeks 28 (RR 1.18; 95% CI 1.06 to 1.32; p=0.002) (HQE). One study examined the number of return visits for any reason over 1 year and found equivalent results (MQE). 25 Nurse practitioner and general practitioner care were equivalent in terms of the number of patients who were referred (HQE), received a prescription (HQE), had investigations ordered or carried out (MQE), were hospitalised at least once (LQE) or had at least one emergency department or urgent care visit (MQE). Based on a meta-analysis of the only two studies of this role that reported costs (2689 patients) with minimal heterogeneity and high-quality evidence, nurse practitioner care compared to general practitioner care resulted in lower mean health services costs per consultation (mean difference: −€6.41; 95% CI −€9.28 to −€3.55; p<0.0001) (2006 euros). 23 28 All patient/provider outcomes in these studies were equivalent or better for the nurse practitioner.
Alternative provider nurse practitioner role in ambulatory specialised care Two non-inferiority trials assessed whether nurse practitioners in alternative provider roles in specialised ambulatory care could function at least at the level of physician comparators, with equal or lower costs. One focused on care of children with eczema 29 30 and the other on performing screening colonoscopies (table 1) . 31 Based on the Cochrane risk of bias assessment, both trials were at low risk of bias. 29 31 The Quality of Health Economic Studies score for one trial was 80 29 and for the other 39. 31 Patient/provider outcomes were assessed using GRADE and are reported in a detailed table in online supplemental file 2.
One trial compared nurse practitioner and dermatologist care in children with eczema. 29 30 The nurse practitioner used treatment protocols, prescribed independently and had access to a dermatologist if needed. Nurse practitioner care was equivalent to dermatologist care in reducing symptom severity and improving quality of life (LQE). Nurse practitioner care resulted in higher parent satisfaction with care (mean difference: 2.1 (95% CI 0.34 to 3.86); p<0.02 (maximum score 32)) (LQE). With respect to health system outcomes (table 2), the nurse practitioner group had lower mean annual family costs per child (mean difference: −€306 (95% CI −€569 to −€43); p=0.02) (LQE). The trial investigators calculated incremental costeffectiveness ratios for two outcomes: quality of life and parent satisfaction. For the infant and child quality of life outcomes, the nurse practitioner resulted in cost-savings, but was associated with a small reduction in quality of life (incremental cost-effectiveness ratio was €925 savings per one point less improvement on the 30-point scale infant quality of life measure and €751 savings per one point less improvement on the 30-point scale child quality of life measure). For parent satisfaction, the nurse practitioner resulted in cost-savings and was associated with improvement in satisfaction (incremental cost-effectiveness ratio was €251 savings per one point more satisfaction in the nurse practitioner group at 12 months). 30 One trial compared one nurse practitioner to two gastroenterologists in independently performing screening colonoscopies. 31 A supervising gastroenterologist was immediately available, but not present in the procedure room. Nurse practitioner care was associated with a higher adenoma and advanced neoplasia detection rate (RR 2.47; 95% CI 1.44 to 4.25; p=0.004) (LQE) and higher patient satisfaction scores ( p=0.042) (MQE). Care was equivalent in terms of procedural pain (LQE), patient willingness to repeat the examination (MQE), cecal intubation depth (MQE), immediate complications, procedure duration (LQE) and hospitalisation due to complications.
Complementary provider nurse practitioner role in specialised ambulatory care Five superiority trials evaluated nurse practitioners in complementary roles comparing nurse practitioner interventions plus usual care to usual care alone. [32] [33] [34] [35] [36] [37] [38] [39] In all five trials, nurse practitioners were added to usual care in specialised ambulatory settings and were compared to usual care alone ( physician-provided care). Four studies limited enrolment to adults with hypercholesterolaemia and coronary heart disease, 32 type 2 diabetes, 34 hypertension and type 2 diabetes, 35 and medically unexplained symptoms. 37 One study included infants and children presenting to an emergency department with an acute illness (table 1). 36 Based on the Cochrane risk of bias assessment, three trials were at low, 32 36 37 one at moderate 34 and one at high risk of bias. 35 Four of the five trials had Quality of Health Economic Studies scores that were less than 40, 34-37 the lowest score being 26. 36 One trial had a Quality of Health Economic Studies score of 77. 32 33 Patient/provider outcomes are reported in detail in online supplemental file 3.
Three trials compared the addition of nurse practitioner care to usual care ( physician-provided care) in chronic disease management. 32 34 35 Of the 26 patient and provider outcomes reported, none favoured usual care, 11 favoured nurse practitioner plus usual care, and 15 were equivalent. Based on a meta-analysis of two studies 32 34 with 400 patients and moderate heterogeneity (I 2 =45%), nurse practitioner plus usual care significantly reduced low-density lipoprotein cholesterol (LDL-C) (mean reduction 11.8 mg/dL; 95% CI 5.1 to 18.6; p=0.0006) (VLQE). Allen et al 32 reported a twofold increase in the proportion of patients with LDL <100 mg/dL at 12 months in the nurse practitioner plus usual care group (RR 1.94; 95% CI 1.44 to 2.61; p=0.001) (VLQE). All other outcomes favouring nurse practitioner plus usual care were graded as low quality evidence and included: reduced glycated haemoglobin ( pooled data; 2 studies; 34 35 366 patients, I 2 =0%; 0.36% reduction; 95% CI 0.04% to 0.68%; p=0.03), reduced fat intake at 1 year (reduction in daily intake 3.7%; 95% CI 1.7% to 5.7%; p=0.0004), 32 reduced saturated fat intake at 1 year (reduction in daily intake 1.4%; 95% CI 0.63% to 2.17%; p=0.004), 32 reduced cholesterol intake at 1 year (reduction in daily intake 62.5 mg; 95% CI 11.5 mg to 113.5 mg; p=0.017), 32 increased physical activity (≥6 metabolically equivalent hours/week: RR 1.56; 95% CI 1.06 to 2.29; p=0.02), 32 increased medication compliance (RR 1.23; 95% CI 1.05 to 1.43; p=0.004), 32 increased patient satisfaction with care (adjusted p=0.04), 34 increased proportion of patients assessing their care provider as at least better than average (RR 1.28; 95% CI 1.08 to 1.52; p=0.04), 34 and increased proportion of patients receiving preventive care and education (RRs ranging from 1.05 to 4.41; p values ranging from 0.06 to <0.001).
As table 3 shows, of nine health system outcomes reported across these studies, one favoured nurse practitioner plus usual care, three favoured usual care and five were equivalent. Based on a meta-analysis of two studies 34 35 with 373 patients and low heterogeneity (I 2 =29%), nurse practitioner plus usual care reduced the number of patients who received care outside the primary care setting over 12-18 months (RR 0.65; 95% CI 0.44 to 0.94; p=0.02) (LQE). In one study, 32 33 the incremental cost-effectiveness ratio for nurse practitioner case management over 1 year was $26.03 per mg/dL reduction in LDL-C and $39.05 per per cent reduction in LDL-C (data not shown). The outcomes favouring usual care were reported in one study 35 and included significantly fewer outpatient visits ( p<0.001), shorter average contact time per patient ( p<0.001) and lower personnel costs ( p<0.001) (LQE).
One study compared nurse practitioner plus usual care to usual care for patients with medically unexplained symptoms and high primary care utilisation; of six patient outcomes, five favoured nurse practitioner plus usual care and one was equivalent (LQE). 37 21 ‡Total incremental cost includes NP salary, laboratory tests, and lipid-lowering medication. Effect estimate favours intervention effect estimate favours usual care . §Reported p value calculated using the χ 2 test represents a significant difference in favour of NP group although the 95% CI suggests otherwise. adj, adjusted; BP, blood pressure; C, control group; CHD, coronary heart disease; ED, emergency department; HMO, health maintenance organisation; I, NP intervention group; LDL-C, low-density lipoprotein cholesterol; MD, mean difference; MedD, median difference; MUS, medically unexplained symptoms; NA, not assessed; NR, not reported; NS, not significant; USD, USA dollar; VA, Veteran's Affairs.
≥80 points on all satisfaction scales ( p<0.01) and taken full doses of antidepressant prescriptions (RR 3.46; 95% CI 2.28 to 5.24; p<0.001). Of six health system outcomes, one favoured usual care and five were equivalent (all LQE). The cost of antidepressant medication was higher in the nurse practitioner plus usual care group (increase of US$192 (2002); 95% CI $41 to $342; p=0.012) which would be consistent with the increased compliance with full doses described above.
One study 36 compared nurse practitioner plus usual care to usual care in reducing inappropriate use of emergency department follow-up care by parents of young children. No patient or provider outcomes were reported and of five health system outcomes reported, one favoured nurse practitioner plus usual care and four were equivalent results (all LQE). Fewer nurse practitioner plus usual care parents made inappropriate use of follow-up ( p<0.05).
DISCUSSION
Our review builds on existing literature 8 10-13 by summarising all trials reported since 1980 that include a health system outcome to address the cost-effectiveness of nurse practitioners in primary and specialised ambulatory care. Strengths of our review include a comprehensive search, inclusion of trials that evaluated formally-trained or licensed nurse practitioners, duplicate study selection and quality assessment, quality assessment using Cochrane risk of bias criteria and the Quality of Health Economic Studies instrument, use of GRADE to evaluate outcome-specific quality of evidence, pooling of data wherever possible, and contact with authors for clarification.
Eleven trials evaluated the nurse practitioner in ambulatory care. Six of these trials evaluated alternative nurse practitioner roles, four in primary care and two in specialised care. Five trials evaluated complementary nurse practitioner roles in specialised care. With respect to overall risk of bias, six trials were at low risk (one alternative primary care, 25 two alternative specialised care 29 31 and three complementary specialised care 32 36 37 ). Four trials were at moderate risk of bias (three alternative primary care 22 24 28 and one complementary specialised care 34 ). One complementary specialised care trial was at high risk of bias. 35 When GRADE was applied to individual patient and provider outcomes, the quality of evidence was highest for alternative nurse practitioner roles in primary care; of the 24 outcomes for which GRADE could be applied, 7 were of high, 5 of moderate and 12 of low quality. Of the 10 outcomes for which GRADE could be applied for alternative nurse practitioner roles in specialised ambulatory care, 3 were moderate and 7 low quality. The quality of evidence for patient and provider outcomes was lowest for complementary nurse practitioner roles in specialised ambulatory care; of the 25 outcomes measurable using GRADE, one was of moderate, 16 of low and 8 of very low quality.
When GRADE was applied to individual health systems outcomes, the quality of evidence was highest for alternative nurse practitioner roles in ambulatory primary care; of the 11 outcomes for which GRADE could be applied, 4 were of high, 5 of moderate, and 2 of low quality. Of the seven outcomes for which GRADE could be applied for alternative nurse practitioner roles in specialised ambulatory care, all were low quality. Similarly, all 16 health systems outcomes measurable using GRADE for complementary nurse practitioner roles in specialised ambulatory care were low quality.
While many of the trials in this review were judged to be of high or moderate quality using the Cochrane risk of bias, many of the GRADE assessments of individual outcomes yielded very low or low quality evidence, which may seem contradictory. Most of the downgrading in GRADE occurred because of indirectness when fewer than 10 nurse practitioners contributed to study findings or were novices (both of which reduce generalisability) or when weak surrogate outcomes were used, or because of imprecision stemming from small sample sizes. Neither indirectness nor imprecision are assessed in the Cochrane risk of bias. To address indirectness, future studies should evaluate larger numbers of experienced nurse practitioners and utilise surrogate end points that have a strong association with the clinical end point of interest. 40 Imprecision occurs when the scatter of data points is so large that there is no meaningful result. To address this, studies should include larger samples to reduce random variability and measure common outcomes that permit data pooling.
Overall, the literature on the cost-effectiveness of nurse practitioners is limited with respect to quantity and quality. It is remarkable that only 11 trials have been conducted that evaluate health systems outcomes of nurse-practitioner-provided care and only 7 measured costs and of these, only 4 assessed costs and outcomes jointly. Appraisal using the Quality of Health Economic Studies instrument found two studies of high quality, one evaluating the alternative nurse practitioner role in specialised ambulatory care 29 30 and the other the complementary nurse practitioner role in specialised ambulatory care. 32 33 Two trials evaluating alternative nurse practitioner roles in ambulatory primary care were of fair quality 22 23 25 and the remaining seven were of poor quality. None of the trials, even those of high quality, used a common outcome, such as quality adjusted life years, which would have allowed comparison of incremental cost-effectiveness ratios across interventions.
Notwithstanding these limitations, as table 4 shows, our review lends some support to the cost-effectiveness of nurse practitioners in the alternative provider role in primary 22 28 and specialised 29 ambulatory care. The evidence is strongest for primary care with a meta-analysis of data from two studies (over 2500 patients) showing lower mean health service costs per consultation when compared to general practitioner care. 22 28 Since meta-analyses were limited to two studies, we could not conduct subgroup analyses to explain why heterogeneity was so high for consultation time and return visits. A network analysis indicated that these outcomes may vary by country. Combining data from studies conducted in the Netherlands 22 and the UK, 28 meta-analyses indicate that general practitioners in the Netherlands have longer consultation times than UK general practitioners (RR 1.71; 95% CI 1.19 to 2.23 min longer) and are more likely to ask patients to return (RR 1.67; 95% CI 1.41 to 1.96).
For the alternative nurse practitioner role, instances of higher resource use in three primary care studies in the UK all relate to length of consultation and/or patient return visits. 23 24 28 This finding was partly explained by nurse practitioners needing to take time to seek a general practitioner to sign prescriptions. 22 24 28 Other contributing factors may have been how appointments were booked, 22 the considerable difference in years of experience between nurse practitioners and comparator general practitioners 22 and because nurse practitioners provided more information to patients about their illness and self-management. 24 Longer consultation times were not observed when nurse practitioners and general practitioners were subject to the same productivity policies, 25 suggesting that structural factors not reported in the trials, for example, receptionist and office supports, influence performance. While longer consultations increase health resource use, these may improve patient satisfaction 24 and potentially decrease resource use over time.
With complementary roles, additional costs and resource use are expected given the added nurse practitioner position and the goal to improve outcomes. In this review, half the patient/provider outcomes favoured nurse practitioners suggesting that the role is effective. Not unexpectedly, outcomes, for example, increases in preventive care and patient education, were associated with increased contact time, visits and costs. 35 Four studies compared costs, but only one assessed costs and outcomes jointly. 32 33 In this study the incremental costs of nurse case 16 where studies at risk in ≤1 category were judged to be at low risk of bias; 2-3 categories at moderate risk; 4-6 at high risk; and 7-8 categories at very high risk of bias.
†The QHES measured the quality of studies with respect to their health economic analysis. [17] [18] [19] The score ranged from 0 to 100 where studies scoring from 0-24 points were judged to be extremely poor quality, 25-49 were poor, 50-74 were fair, and 75-100 were high quality. QHES, Quality of Health Economic Studies instrument. management over 1 year based on the nurse's time, lipid-lowering drug costs, and laboratory monitoring costs were $26/mg/dL reduction in LDL-C levels and $39 per per cent reduction in LDL-C. Determining if the additional cost is warranted is challenging because of the uncertainty in the strength of the relationship between the surrogate marker of LDL-C and patient-important outcomes such as cardiovascular events.
Finally it must be recognised that determination of cost-effectiveness is fraught with methodological and ethical challenges. For example, the potential cost-savings associated with nurse practitioner alternative primary and specialised ambulatory care provider roles appear to rely on the lower salary of nurse practitioners relative to physicians 23 41 and the extent to which the nurse practitioner role is autonomous. 42 This positions nurse practitioners as equally effective healthcare providers who bear the same responsibility and accountability as their physician colleagues, but who are less well compensated. The issue of pay equity, especially for a largely female profession, is undeniable. On the other hand, few studies that measure cost-effectiveness consider the cost implications of the contextual differences in the role expectations of physicians and nurse practitioners or the professional expenses that each is expected to cover, for example, the overhead costs associated with a private business. The complexities are daunting. Yet as the grim consequences of chronic disease and social inequities continue to be revealed, the need for evidence of the cost-effectiveness of nurse practitioners in alternative and complementary roles in ambulatory care has never been greater. Future studies should include a health economist who can guide high quality economic analyses that evaluate quality of life and long-term outcomes such as the prevention of morbidity and mortality (M Lee, DA Marshall. Critical assessment of the cost-effectiveness literature on Advanced Practice Nurses (APNs) and development of a framework for future economic evaluations of APN roles. Unpublished thesis, University of Calgary, 2012).
CONCLUSION
Nurse practitioners in alternative provider ambulatory primary care roles have equivalent or better patient outcomes than comparators and are potentially cost-saving. Evidence for their cost-effectiveness in alternative provider specialised ambulatory care roles is promising, but limited by the few studies. While some evidence indicates nurse practitioners in complementary provider specialised ambulatory care roles improve patient outcomes, their cost-effectiveness requires further study. 
